The urine test may be as effective as the smear test for cervical cancer prevention and may significantly increase participation rates for screening, a study has found.
The research, published in the BMJ Open magazine, found that urine testing was as good as the cervical smear in collecting high-risk human papillomavirus (HPV), the virus that causes cervical cancer.
Researchers at the University of Manchester in the UK said a urine test may help increase the number of women being screened for cervical cancer.
Urine testing may play a role in the developing world, where cervical cancer is up to 15 times more common and the smear test virtually nonexistent.
About one in 20 women have abnormal abnormalities that may turn out to be cancer and are referred to colposcopy, where the cervix is examined under magnification, allowing abnormal areas to be seen, sampled, and treated before they cause cancer, the researchers said. researchers.
According to the team, cervical swab specimens, self-collected vaginal samples and urine samples are all effective in detecting high-risk HPV infection.
Cervical cancer is more common in women between the ages of 30 and 35. However, the precancerous stage is detectable in the 5 to 10 years prior to this, when up to one-third of women do not attend the bacilloscopy test.
"We are very excited about this study, which we believe has the potential to significantly increase participation rates for screening for cervical cancer in a key demographic group"
said Emma Crosbie, who led the study.